Phase III study comparing vinorelbine-gemcitabine with vinorelbine-carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial

Fløtten, Ø., Bremnes, R. M., Grønberg, B. H., Sundstrøm, S. H., Amundsen, T., Rolke, H., Aasebø, U., hornslien, t., Wentzel-Larsen, T., & von Plessen, C. (2010 June). Phase III study comparing vinorelbine-gemcitabine with vinorelbine-carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. Paper presented at ASCO Annual meeting, Chicago.